Moderna, Inc. (MRNA) stock analysis
Arxanth's stance on MRNA on three horizons, as of Nov 11, 2026:
- Short term (days): Neutral now. By session: Over the last 28 sessions (Oct 5 – Nov 11): Lean Bullish on 2, Neutral on 25, Lean Bearish on 1. The last session read Neutral, as every session since Oct 27 (12 sessions); before that, Lean Bearish.
- Medium term (weeks): Neutral now. By session: Over the last 30 sessions (Oct 5 – Nov 13): Neutral on 30. Every session in this window read Neutral.
- Long term (months): Neutral now. By session: Over the last 29 sessions (Oct 6 – Nov 13): Neutral on 29. Every session in this window read Neutral.
What was published each session. Not a measure of performance.
Three agents vote on each horizon and a fourth reads the options map. Where they disagree, the read shows the disagreement rather than resolving it. The Stance history on this page shows how the stance on each horizon moved over the last 7 or 30 sessions, against the price.
Why the stance, its reference levels, the agents' votes, the risk read and the options range are in the Arxanth app for iPhone and iPad, where every plan starts with a 14-day free trial.
SPY's full read is open to everyone: arxanth.com/#/t/SPY.
Other names on Arxanth: ServiceNow, Inc. (NOW) · Vanguard Total Stock Market ETF (VTI) · Verizon Communications Inc. (VZ) · Western Digital Corporation (WDC) · Uber Technologies, Inc. (UBER) · UnitedHealth Group Incorporated (UNH) · Netflix, Inc. (NFLX) · Eli Lilly and Company (LLY).
Model-generated analytical output, not a trade recommendation. Arxanth is a decision-support and research tool. It is not a broker or execution venue and cannot place or influence orders. For informational purposes only. Not financial advice. Past performance does not guarantee future results. Arxanth by Arxora, LLC.